Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4276 to 4290 of 8314 results

  1. Assessment of disease severity and impact:- In children, young people and adults with psoriasis, can tools be developed and/or existing ones further refined and validated to: - assess disease severity and impact in both non-specialist and specialist healthcare settings, to facilitate assessment, appropriate referral, treatment planning and measurement of outcomes - measure burden and cumulative effect of disease activity, severity and impact for people with both psoriasis and psoriatic arthritis?

    Recommendation ID CG153/1 Question Assessment of disease severity and impact:- In children, young people and adults with psoriasis, can

    Research recommendation
    Published
    9 June 2015

  2. Assessment tools for health promotion:- What are the most effective tools to determine the health promotion needs of people in prison?

    Recommendation ID NG57/4 Question Assessment tools for health promotion:- What are the most effective tools to determine the health promotion

    Research recommendation
    Published
    10 February 2017

  3. Relationship between attachment difficulties and complex trauma:- This research recommendation is composed of 2 parts:Assess the prevalence of attachment difficulties (including attachment disorders), complex trauma and the combination of both in children and young people in the care system and on the edge of care.Investigate the effect of various factors, such as multiple placements, on the likelihood of having attachment difficulties, complex trauma or both.

    Recommendation ID NG26/5 Question Relationship between attachment difficulties and complex trauma:- This research recommendation is composed

    Research recommendation
    Published
    11 December 2015

  4. A trial comparing the long-term effectiveness (beyond 24 weeks) of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate and placebo would be beneficial. It should collect utility data as well as walking distance outcomes.

    Recommendation ID TA223/1 Question A trial comparing the long-term effectiveness (beyond 24 weeks) of cilostazol, naftidrofuryl oxalate

    Research recommendation
    Published
    9 June 2015

  5. Prevention of prolonged pregnancy: At what gestational age should induction of labour be offered in the subgroups of women who may be more likely to experience adverse outcomes if pregnancy continues?

    Recommendation ID NG207/01 Question Prevention of prolonged pregnancy: At what gestational age should induction of labour be offered in

    Research recommendation
    Published
    15 December 2021

  6. Anti-reflux therapy as a treatment for idiopathic pulmonary fibrosis:- Is anti-reflux therapy an effective treatment for idiopathic pulmonary fibrosis?

    Recommendation ID CG163/5 Question Anti-reflux therapy as a treatment for idiopathic pulmonary fibrosis:- Is anti-reflux therapy an effective

    Research recommendation
    Published
    9 June 2015

  7. What is the clinical and cost effectiveness of chlorhexidine in alcohol at different concentrations in the prevention of surgical site infection when applied to the skin before incision?

    Recommendation ID NG125/3 Question What is the clinical and cost effectiveness of chlorhexidine in alcohol at different concentrations

    Research recommendation
    Published
    16 August 2019

  8. What is the clinical and cost effectiveness of a block and replace regimen compared with a titration regimen of antithyroid drugs for Graves' disease?

    Recommendation ID NG145/8 Question What is the clinical and cost effectiveness of a block and replace regimen compared with a titration

    Research recommendation
    Published
    10 February 2020

  9. Are there subgroups of people with Graves' disease who have a particularly good response to antithyroid drugs?

    Recommendation ID NG145/3 Question Are there subgroups of people with Graves' disease who have a particularly good response to antithyroid

    Research recommendation
    Published
    10 February 2020

  10. What is the clinical and cost effectiveness of different durations of antithyroid drug regimens for people with T3 thyrotoxicosis due to Graves' disease?

    Recommendation ID NG145/6 Question What is the clinical and cost effectiveness of different durations of antithyroid drug regimens for

    Research recommendation
    Published
    10 February 2020

  11. Decision-to-birth interval (category 2 urgency): A prospective study to determine whether the decision-to-birth interval has an impact on maternal and neonatal outcomes when there is a category 2 level of urgency for caesarean birth.

    Recommendation ID NG192/03 Question Decision-to-birth interval (category 2 urgency): A prospective study to determine whether the decision-to-birth

    Research recommendation
    Published
    24 April 2023

  12. Augmentative and alternative communication systems:- Are augmentative and alternative communication systems clinically and cost effective in promoting  communication for adults with cerebral palsy who have communication difficulties?

    Recommendation ID NG119/6 Question Augmentative and alternative communication systems:- Are augmentative and alternative communication

    Research recommendation
    Published
    8 March 2019

  13. Awareness of risk among black, Asian and other minority ethnic groups: Are black, Asian and other minority ethnic groups aware that they are at the same risk of type 2 diabetes and mortality at a lower BMI, compared with the white population?

    Recommendation ID CG189/10 Question Awareness of risk among black, Asian and other minority ethnic groups: Are black, Asian and other minority

    Research recommendation
    Published
    30 September 2022

  14. Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are receiving/have recently received radiotherapy (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of severe COVID-19 illness or death?

    Recommendation ID NG162/1 Question Risk of radiotherapy in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are

    Research recommendation
    Published
    21 October 2021

  15. Risk of systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are receiving/have recently received systemic anticancer treatment (SACT) (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of severe COVID-19 illness or death?

    Recommendation ID NG161/1 Question Risk of systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and

    Research recommendation
    Published
    21 October 2021